SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 12th, 2015 • Tapimmune Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 12, 2015, is by and among TapImmune Inc., a Nevada corporation with offices located at 1551 Eastlake Avenue East, Suite 100, Seattle, Washington 98102 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
OLYMPUS SECURITIES, LLCLetter Agreement • January 12th, 2015 • Tapimmune Inc • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIALLetter Agreement • January 12th, 2015 • Tapimmune Inc • Pharmaceutical preparations • New York
Reference is made to the exclusive engagement letter (the “Engagement Letter”), dated July 29, 2014, by and between TapImmune Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which Wainwright shall serve as the exclusive investment bank of the Company during the “Term” (as defined in the Engagement Letter).
